These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Hypersensitivity reaction to etoposide. A case report]. Mullera Martí M; Riba Solé M; Fernández de Gamarra Martínez E; Mangues Bafalluy MA Farm Hosp; 2014 May; 38(3):255-6. PubMed ID: 24951914 [TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity reactions to etoposide. Hoetelmans RM; Schornagel JH; ten Bokkel Huinink WW; Beijnen JH Ann Pharmacother; 1996 Apr; 30(4):367-71. PubMed ID: 8729891 [TBL] [Abstract][Full Text] [Related]
14. [Use of pertuzumab and docetaxel desensitization in oncological patient; apropos of a case]. Guerrero Bautista R; Chica Marchal A; García Simón MS; Ferris Villanueva E; Pérez Cañadas P; De Andrés Bautista M Farm Hosp; 2014 Nov; 38(6):491-3. PubMed ID: 25542663 [No Abstract] [Full Text] [Related]
15. Oral etoposide-induced leucocytoclastic vasculitis in a patient with lung carcinoma. Turken O; Karagoz B; Bilgi O; Doğan B; Kandemir EG; Kunter E J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1297-8. PubMed ID: 17894749 [No Abstract] [Full Text] [Related]
16. Safe and Time-Saving Desensitization Protocol to Intravenous Etoposide. Gómez-Duque M; Sala-Cunill A; Farriols A; Cardona V; Luengo O J Allergy Clin Immunol Pract; 2016; 4(4):793-4. PubMed ID: 27393789 [No Abstract] [Full Text] [Related]
17. Successful rapid desensitization to intravenous bevacizumab using a 14-step protocol: Case report. Williams SJ; Khokhar A; Gharib A J Allergy Clin Immunol Pract; 2017; 5(6):1746-1747. PubMed ID: 28606785 [No Abstract] [Full Text] [Related]
18. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Feldweg AM; Lee CW; Matulonis UA; Castells M Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432 [TBL] [Abstract][Full Text] [Related]
19. Successful desensitization of two patients with ALK-positive lung cancer and hypersensitivity to crizotinib. Awad MM; Lax TP; Slawski BR; Shaw AT J Thorac Oncol; 2014 Nov; 9(11):1726-8. PubMed ID: 25436807 [TBL] [Abstract][Full Text] [Related]
20. [Long-term oral administration of etoposide in the treatment of patients with advanced non-small-cell carcinoma of the lung. The second phase of a clinical study]. Jeremić B; Djurić Lj; Jevremović S; Stefanović K; Matović M Srp Arh Celok Lek; 1996; 124(3-4):65-8. PubMed ID: 9102821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]